Peer-Reviewed Journal Details
Mandatory Fields
Ranera, B,Antczak, D,Miller, D,Doroshenkova, T,Ryan, A,McIlwraith, CW,Barry, F
2016
March
Equine Veterinary Journal
Donor-derived equine mesenchymal stem cells suppress proliferation of mismatched lymphocytes
Published
()
Optional Fields
horse mesenchymal stem cell immunosuppression major histocompatibility complex mismatch lymphocyte BONE-MARROW PERIPHERAL-BLOOD IN-VITRO STROMAL CELLS T-CELLS IMMUNOSUPPRESSIVE PROPERTIES CYTOKINE PRODUCTION EXPRESSION TENDON RESPONSES
48
253
260
Reasons for performing studyRecently, it has been shown that mesenchymal stem cells (MSCs) do not express the major histocompatibility complex (MHC) II antigen and are able to inhibit proliferation of MHC-mismatched stimulated lymphocytes, enabling their use as in vivo allogeneic transplants. However, prior to clinical application of allo-MSCs, in vitro tests are required to confirm the safety of treatment protocols.ObjectivesTo evaluate the immunosuppressive capabilities of equine bone-marrow-derived MSCs (BM-MSCs) on MHC-mismatched lymphocytes.Study designIn vitro experiment.MethodsPhytohaemagglutinin-stimulated peripheral blood mononuclear cells (PBMCs) from 3 Thoroughbreds (recipients) were co-cultured with mismatched BM-MSCs from 3 Connemara ponies (donors). Proliferation of lymphocytes was monitored by carboxyfluorescein succinimidyl ester labelling and analysed by flow cytometry. In total, 6 horses were haplotyped using microsatellites to confirm mismatching. Optimisation of the conditions to stimulate Thoroughbred lymphocytes and titration of equine anti-CD4 and anti-CD8 antibodies were performed. Connemara pony and Thoroughbred BM-MSCs were isolated, expanded and characterised by tri-lineage differentiation. Finally, BM-MSCs from both breeds were set up in co-culture at different ratios with stimulated Thoroughbred lymphocytes. Proliferation of CD4(+) and CD8(+) cells was determined by flow cytometry.ResultsA high proportion of CD4/CD8 double-positive lymphocytes were found in freshly isolated PBMCs, although this percentage decreased after 4 days of culture. Mismatched BM-MSCs inhibited proliferation of stimulated lymphocytes in a dose-dependent manner, with the greatest suppression occurring at a 1:10 ratio of BM-MSCs to PBMCs. Proliferation of CD4(+) and CD8(+) subpopulations decreased in 1:10 co-culture, with statistical significance in the case of CD8(+) cells, while that of the CD4/CD8 double-positive population was similar to the phytohaemagglutinin control.ConclusionsThe results demonstrate dose-dependent immunosuppression of stimulated lymphocytes by mismatched equine BM-MSCs, supporting their future application in allo-MSC clinical treatments.
10.1111/evj.12414
Grant Details
Publication Themes